Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
Saved in:
Main Authors: | Tiago Nunes, Claudio Bernardazzi, Heitor S. de Souza |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/423957 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase
by: Keiichi Mitsuyama, et al.
Published: (2006-01-01) -
Inflammasome in Intestinal Inflammation and Cancer
by: Tiago Nunes, et al.
Published: (2013-01-01) -
Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
by: Donatella Comito, et al.
Published: (2012-01-01) -
High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease
by: Lu Song, et al.
Published: (2013-01-01) -
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01)